Loading company details...
Latest Form 4 (Jul 29, 2026): Kristian Reich (Chief Scientific Officer): Sale of 1,100 shares, $22.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Kristian Reich, Chief Scientific Officer | Sale | 1,100 | $22.0K |
| Jul 23, 2026 | Kristian Reich, Chief Scientific Officer | Sale | 50,000 | $1.00M |
| Jul 21, 2026 | Kristian Reich, Chief Scientific Officer | Sale | 43,700 | $877.9K |
| Jul 20, 2026 | Kristian Reich, Chief Scientific Officer | Sale | 16,105 | $322.3K |
| Jul 13, 2026 | Da Silva Jorge Santos, Chief Executive Officer | Sale | 33,936 | $679.1K |
| Jul 2, 2026 | Da Silva Jorge Santos, Chief Executive Officer | Sale | 47,775 | $956.9K |
| Jun 23, 2026 | Matthias Bodenstedt, Chief Financial Officer | Sale | 39,120 | $862.2K |
| Jun 22, 2026 | BVF PARTNERS L P/IL | Grant/Award | 22,195 | n/a |
| Jun 18, 2026 | Matthias Bodenstedt, Chief Financial Officer | Sale | 15,082 | $296.8K |
| Jun 18, 2026 | Andrew John Phillips | Grant/Award | 22,195 | n/a |